Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Zynerba Pharma CS
(NQ:
ZYNE
)
3.555
USD
-0.055 (-1.52%)
Official Closing Price
Updated: 7:25 PM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Zynerba Pharma CS
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
First Week of ZYNE March 19th Options Trading
January 21, 2021
Investors in Zynerba Pharmaceuticals Inc (ZYNE) saw new options become available this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Tags
Stocks
From
Market News Video
Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences
January 04, 2021
From
GlobeNewswire News Releases
First Week of ZYNE August 2021 Options Trading
December 18, 2020
Investors in Zynerba Pharmaceuticals Inc (ZYNE) saw new options become available this week, for the August 2021 expiration. One of the key data points that goes into the price an option buyer is...
Tags
Stocks
From
Market News Video
80 Biggest Movers From Yesterday
December 18, 2020
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 473.7% to close at $33.96 on Thursday. Scopus BioPharma’s ...
Tags
SQFT
Health Care
Movers
From
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 17, 2020
Gainers PainReform (NASDAQ:PRFX) stock increased by 41.55% to $6.23 during Thursday's regular session. ...
Tags
LIXT
JAGX
health care stocks
From
Benzinga
50 Stocks Moving In Thursday's Mid-Day Session
December 17, 2020
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 500% to $35.52. Scopus BioPharma’s filing showed registration ...
Tags
BCDA
Trading Ideas
RAD
From
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 17, 2020
Gainers Seneca Biopharma (NASDAQ:SNCA) shares rose 49.4% to $1.16 during Thursday's pre-market session. The ...
Tags
Market News
HJLI
EOLS
From
Benzinga
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
December 17, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CERE
Small Cap
RVMD
From
Benzinga
Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome
December 17, 2020
From
GlobeNewswire News Releases
Immunome Provides Organizational Update: Appoints Richard Baron to its Board of Directors and Sandra Stoneman as Chief Legal Officer and Corporate Secretary
December 10, 2020
Immunome appoints Richard Baron to BOD and Sandra Stoneman as Chief Legal Officer and Corporate Secretary
From
Business Wire News Releases
Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc.
December 09, 2020
Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc. (ZYNE)
From
Business Wire News Releases
The Law Offices of Frank R. Cruz Announces Investigation of Zynerba Pharmaceuticals (ZYNE) on Behalf of Investors
December 07, 2020
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Zynerba Pharmaceuticals (“Zynerba” or the “Company”) (NASDAQ: ZYNE) concerning whether the board...
From
Business Wire News Releases
Zynerba Pharmaceuticals Presents New Data in Two Posters at the 2020 Annual Meeting of the American Epilepsy Society (AES)
December 04, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the 2020 Virtual Annual Meeting of the American Epilepsy Society (AES)
November 23, 2020
From
GlobeNewswire News Releases
The Week In Cannabis: Stocks Down Amid Earnings Season, Argentina Regulates Medical Marijuana
November 14, 2020
Cannabis stocks were back in the red this week, retreating from post-election highs amid an earnings-heavy period. Over the five ...
Tags
MJ
CNPOF
TGODF
From
Benzinga
Earnings Update: Aurora, Canopy Growth, Canopy Rivers And Zynerba Each Post Results
November 09, 2020
Aurora Posts Q1 EBITDA Loss, ExpectsPositive EBITDA In Q2 Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) consolidated net ...
Tags
Canopy Rivers
ACB
Markets
From
Benzinga
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
November 09, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Presents Data Supporting FMR1 Methylation Status as a Correlate to Fragile X Syndrome Severity at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th An
October 15, 2020
From
GlobeNewswire News Releases
New Data Describing Statistically Significant Results from the Phase 2 BRIGHT Trial in Patients with Autism Spectrum Disorder (ASD) Presented at the Virtual Joint 16th International Child Neurology Co
October 15, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry (AACAP) 2020 Annual Meeting
October 08, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Virtual Joint 49th Annual Child Neurology Society & 16th International Child Neurology Society Congress (CNS-ICNA) Meeting
October 08, 2020
From
GlobeNewswire News Releases
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
October 08, 2020
Gainers Alphatec Holdings (NASDAQ:ATEC) stock rose 25.29% to $8.62 during Thursday's pre-market session. The company's ...
Tags
GOVX
ZYNE
Movers
From
Benzinga
Legalization Efforts Continue to Drive the Cannabis Market Growth
September 25, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion Syndrome
September 17, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Provides Update on Recent Milestones
September 14, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences
September 10, 2020
From
GlobeNewswire News Releases
The Pure US Cannabis ETF Started Trading Today: Here Are Its Holdings
September 02, 2020
The AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) started trading on Wednesday, becoming the first U.S.-listed active ETF focused ...
Tags
GRWG
NBEV
SSPK
From
Benzinga
More People Turn to CBD as its List of Applications Grows
August 14, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
August 10, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth Conference
August 06, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.